article thumbnail

J&J, GSK and other companies knowingly marketed ineffective decongestants, lawsuits claim

Fierce Pharma

Questions first circulated about decongestant pills containing phenylephrine in 2007. Several companies, including Johnson & Johnson, GSK, Procter & Gamble and Walgreens, face class-action lawsuits that claim the drugmakers knew that over-the-counter cold and flu pills containing phenylephrine did not work as advertised.

Marketing 283
article thumbnail

Fierce Pharma Asia—Sun’s Taro buyout, Eli Lilly’s XtalPi collab, Yuhan’s cancer candidate

Fierce Pharma

Sun Pharma picked up Taro Pharmaceutical Industries 16 years after its initial offer. Sun Pharma snapped up Taro Pharmaceutical Industries in a $307 million deal after its initial 2007 offer. Eli Lilly and XtalPi linked up in a $250 million deal. |

Pharma 147
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Health literacy is a huge problem

World of DTC Marketing

University of Connecticut, 2007.). This is a huge opportunity for pharma to help patients. One of the biggest issues of pharma websites continues to be that content is often at a college reading level forcing people to look elsewhere for the information they need to make treatment choices. economy up to $236 billion every year.

article thumbnail

Our healthcare has failed us

World of DTC Marketing

The adult obesity rate passed 40 percent nationally for the first time according to the 2017–2018 National Health and Nutrition Examination Survey (NHANES), a 26 percent jump from 2007–2008. Pharma should include warnings about obesity on every drug product page that could be caused by obesity.

article thumbnail

American healthcare is unsustainable

World of DTC Marketing

The health insurance, PBM’s, and big pharma didn’t accumulate their massive wealth by running deficits. Between 2007 and 2014, prices for inpatient and outpatient hospital care rose much faster than physician prices, according to a 2019 study in Health Affairs.

article thumbnail

Pharma Sales To Med Device CEO: The Jeff Smith Story Part 2

Evolve Your Success

Pharma Sales To Med Device CEO: The Jeff Smith Story Part 2. It was 2007 and 2008. The post Pharma Sales To Med Device CEO: The Jeff Smith Story Part 2 appeared first on Evolve Your Success. — Watch the episode here. Listen to the podcast here. We continue our interview with Jeff Smith. What year was this? Love the show?

Sales 130
article thumbnail

NK cell immunotherapy: what’s next in clinical development?

European Pharmaceutical Review

Yannis Morel, Executive Vice President of product portfolio strategy and business development of Innate Pharma SA, offers insight on engineering antibodies to develop antibody-based NK cell therapeutics. As a biotech, what work does Innate Pharma do in the biopharma industry? Can you describe Innate Pharma’s clinical stage pipeline?

Pharma 124